D. E. Shaw & Co., Inc. Pfizer Inc Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Pfizer Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 12,307,600 shares of PFE stock, worth $344 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

12,307,600

Previous 8,900,100 38.29%

Holding current value

$344 Million

Previous $256 Million 33.29%

% of portfolio

0.3%

Previous 0.24%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $253 Million - $290 Million	9,770,933 Added 67.28%	24,292,919 $674 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $35.8 Million - $46.5 Million	1,369,112 Added 10.41%	14,521,986 $418 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $214 Million - $250 Million	6,675,541 Added 103.06%	13,152,874 $436 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $41.2 Million - $47.7 Million	-1,141,180 Reduced 14.98%	6,477,333 $238 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $14.2 Million - $18.5 Million	361,509 Added 4.98%	7,618,513 $311 Million

Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $184 Million - $240 Million	4,402,503 Added 154.23%	7,257,004 $372 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $1.21 Million - $1.47 Million	-27,604 Reduced 0.96%	2,854,501 $125 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $324 Million - $385 Million	-6,973,010 Reduced 70.76%	2,882,105 $151 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $299 Million - $370 Million	6,533,107 Added 196.66%	9,855,115 $510 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $48 Million - $71.1 Million	-1,160,547 Reduced 25.89%	3,322,008 $196 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $60.5 Million - $77.7 Million	-1,541,261 Reduced 25.59%	4,482,555 $193 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $164 Million - $186 Million	4,572,946 Added 315.19%	6,023,816 $236 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $10 Million - $11.3 Million	-299,828 Reduced 17.13%	1,450,870 $52.6 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $144 Million - $183 Million	-4,306,383 Reduced 71.1%	1,750,698 $64.4 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $117 Million - $138 Million	-3,694,687 Reduced 37.89%	6,057,081 $222 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $60.1 Million - $72.9 Million	-1,995,164 Reduced 16.98%	9,751,768 $319 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $225 Million - $322 Million	8,338,430 Added 244.64%	11,746,932 $383 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $4.47 Million - $5.07 Million	135,707 Added 4.15%	3,408,502 $134 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $8.99 Million - $11.7 Million	-276,769 Reduced 7.8%	3,272,795 $118 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $270 Million - $303 Million	-7,302,650 Reduced 67.29%	3,549,564 $154 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $387 Million - $426 Million	10,328,490 Added 1972.12%	10,852,214 $461 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $6.26 Million - $7.14 Million	162,686 Added 45.06%	523,724 $22.9 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $32.7 Million - $39.7 Million	-948,881 Reduced 72.44%	361,038 $15.9 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $30.8 Million - $32.8 Million	-932,652 Reduced 41.59%	1,309,919 $47.5 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $29.6 Million - $34.4 Million	-928,965 Reduced 29.29%	2,242,571 $79.6 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $619,999 - $657,840	18,641 Added 0.59%	3,171,536 $115 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $97.7 Million - $108 Million	3,152,895	3,152,895 $113 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account